Appropriations Requests for : YesRx

1. Cosponsoring legislators:

No Cosponsors

Recipient Information

2. Intended legislatively directed spending item recipient:

YesRx

3. Physical address of legislatively directed spending item recipient and the intended location of the project or activity:

1700 Cherokee Rd, Ann Arbor, MI 48104

4. The recipient's employer identification number:

932067518

Funding Details

5. Requested amount of the legislatively directed spending item:

$3,000,000.00

6. What is the purpose and how does the legislatively directed spending item provide a public benefit that is an appropriate use of taxpayer money?

YesRx is Michigan’s statewide cancer drug repository network that manages our state’s inventory of cancer medication donated by individuals for use by Michigan residents. The donated cancer medication is provided for free to patients in need due to high medication costs, insurance delays, or other barriers impacting their access to care. YesRx enables Public Act 416 to benefit residents by activating existing infrastructure across the state, eliminating redundancies, and adapting to varying settings to connect patients and clinicians to the cancer drug repository program. A state appropriation allocated to YesRx would be used to meet the 14x increase in resident need by making access to free cancer medication and support for donating cancer medication a more effective resource to improve cancer care delivery in Michigan. State funding would automate some of the manual services that the two full time employees perform resulting in enhanced efficiency of free medication distribution to clinics for patients. Automating their manual systems would allow YesRx to continue expanding their partnerships across the state with a goal of serving 100% of Michigan counties (currently serving 95%).

7. Has the legislatively directed spending item previously received or been awarded any of the following types of funding in the past 5 years?

No previous funding received

8. Estimated time frame for completion of the legislatively directed spending item project:

The estimated time frame for completion is by the end of fiscal year 2028

Additional Information For Nonprofit Corporations

9. Is the recipient a nonprofit corporation?

Yes

4. Officers and active members on the board of directors:

Siobhan Norman (Founder and CEO) Emily Mackler, PharmD, BCOP (Founder and Chief Medical Officer) Farah Jalloul-Rizk, PharmD, MBA Rosalie Tocco-Bradley, PhD, MD, MHSA Philip J. Stella, MD

Certification By Sponsoring Legislator

• "I certify that my immediate family members, legislative staff members, and I have no direct or indirect pecuniary interest in the requested legislatively directed spending item."
• "I certify that the intended recipient of this legislatively directed spending item is not a for-profit entity."
• "I certify that the information in this form is true to the best of my knowledge."

Senator Jeff Irwin